secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2024-01-26T23:59:59+00:00
Accession:  0001193125-24-015722
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney releases updated corporate presentation; no specific financial or clinical updates
--------------------------------------------------------------------------------

- Company filed an updated investor presentation under Item 7.01 for January 2024.
- Presentation highlights REACT renal autologous cell therapy for dialysis prevention.
- No new financial data, clinical trial results, or guidance changes were disclosed.
- Presentation is available on the company's investor relations website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000119312524015722/0001193125-24-015722-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000119312524015722/d182870d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-015722

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer